Alloclamide
Jump to navigation
Jump to search
Clinical data | |
---|---|
Trade names | Pectex, Tuselin |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C16H23ClN2O2 |
Molar mass | 310.82 g·mol−1 |
3D model (JSmol) | |
| |
|
Alloclamide (Pectex, Tuselin) is an antitussive and antihistamine drug marketed in Finland and Spain. It has never been marketed in the US.
It is sold as an oral solution, containing 6.25 mg/mL alloclamide. The recommended dosage for adults is 25 mg three to four times daily. Adverse effects include constipation and sedation.[1]
References
- ^ Schlesser JL (1991). Drugs Available Abroad, 1st Edition. Derwent Publications Ltd. p. 6. ISBN 0-8103-7177-4.
Categories:
- Articles with short description
- Short description matches Wikidata
- Chemical pages without DrugBank identifier
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Antitussives
- Antihistamines
- Diethylamino compounds
- Chlorobenzene derivatives
- Benzamides
- All stub articles
- Pharmacology stubs